Weill Cornell Medicine associate professor Gregory F. Sonnenberg has been awarded a five-year, $3.26 million grant from the National Institutes of Health to investigate the underlying mechanisms of inflammatory bowel disease.
A multi-institution team led by a Weill Cornell Medicine scientist has been approved for $30 million in funding from the Patient-Centered Outcomes Research Institute to study heart procedure outcomes in underrepresented groups.
Can “resume padding” – the enhancing of one’s CV, as in the Rep. George Santos case – ultimately have a positive effect on society in the grand scheme of things? Two Cornell researchers think so.
During the COVID-19 pandemic, many U.S. hospitals had overcapacity intensive care units while other area hospitals had open ICU beds available, a phenomenon known as “load imbalance.”
The Cornell University Hospital for Animals now has the capability of cleansing patients’ blood outside of their bodies, opening the door to new treatment options, including dialysis for animals with kidney failure.
Is artificial intelligence beginning to “understand” humor? In experiments using the New Yorker Cartoon Caption Contest as a testbed, researchers found that it’s making some progress, but isn’t quite there yet.
Cornell researchers have successfully transferred key regions of a highly efficient red algae into a tobacco plant to dramatically improve plant productivity and increase carbon sequestration.
A Cornell-led study provides the strongest evidence yet that omega-3 fatty acids, which are abundant in fish and fish oil supplements, may be important for lung health.
An interdisciplinary research team received a five-year, $2 million grant from the National Science Foundation to develop a new generation of biosynthetic lubricants that have the potential to treat arthritis and reduce the painful friction of artificial joints.
